MR tracking of transplanted cells with "positive contrast" using manganese oxide nanoparticles

Magn Reson Med. 2008 Jul;60(1):1-7. doi: 10.1002/mrm.21622.

Abstract

Rat glioma cells were labeled using electroporation with either manganese oxide (MnO) or superparamagnetic iron oxide (SPIO) nanoparticles. The viability and proliferation of SPIO-labeled cells (1.9 mg Fe/ml) or cells electroporated with a low dose of MnO (100 microg Mn/ml) was not significantly different from unlabeled cells; a higher MnO dose (785 microg Mn/ml) was found to be toxic. The cellular ion content was 0.1-0.3 pg Mn/cell and 4.4 pg Fe/cell, respectively, with cellular relaxivities of 2.5-4.8 s(-1) (R(1)) and 45-84 s(-1) (R(2)) for MnO-labeled cells. Labeled cells (SPIO and low-dose MnO) were each transplanted in contralateral brain hemispheres of rats and imaged in vivo at 9.4T. While SPIO-labeled cells produced a strong "negative contrast" due to the increase in R(2), MnO-labeled cells produced "positive contrast" with an increased R(1). Simultaneous imaging of both transplants with opposite contrast offers a method for MR "double labeling" of different cell populations.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cell Transplantation*
  • Contrast Media*
  • Electroporation
  • Ferric Compounds
  • Glioma
  • Magnetic Resonance Imaging / methods*
  • Manganese Compounds*
  • Metal Nanoparticles*
  • Oxides*
  • Rats
  • Rats, Inbred F344
  • Tumor Cells, Cultured

Substances

  • Contrast Media
  • Ferric Compounds
  • Manganese Compounds
  • Oxides
  • ferric oxide
  • manganese oxide